Justyna Aleksandra, Dzikowska-Diduch Olga, Pacho Szymon, Ciurzyński Michał, Skowrońska Marta, Wyzgał-Chojecka Anna, Piotrowska-Kownacka Dorota, Pruszczyk Katarzyna, Pucyło Szymon, Sikora Aleksandra, Pruszczyk Piotr
Department of Internal Medicine & Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland.
1st Department of Radiology, Medical University of Warsaw, 02-091 Warsaw, Poland.
J Clin Med. 2022 Nov 30;11(23):7100. doi: 10.3390/jcm11237100.
Background: Decreased hemoglobin concentration was reported to predict long term prognosis in patients various cardiovascular diseases including congestive heart failure and coronary artery disease. We hypothesized that hemoglobin levels may be useful for post discharge prognostication after the first episode of acute pulmonary embolism. Therefore, the aim of the current study was to evaluate a potential prognostic value of a decreased hemoglobin levels measured at admission due to the first episode of acute PE for post discharge all cause mortality during at least 2 years follow up. Methods: This was a prospective, single-center, follow-up, observational, cohort study of consecutive survivors of the first PE episode. Patients were managed according to ESC current guidelines. After the discharge, all PE survivors were followed for at least 24 months in our outpatient clinic. Results: During 2 years follow-up from the group of 402 consecutive PE survivors 29 (7.2%) patients died. Non-survivors were older than survivors 81 years (40−93) vs. 63 years (18−97) p < 0.001 presented higher sPESI 2 (0−4) vs. 1 (0−5), p < 0.001 driven by a higher frequency of neoplasms (37.9% vs. 16.6%, p < 0.001); and had lower hemoglobin (Hb) level at admission 11.7 g/dL (6−14.8) vs. 13.1 g/dL (3.1−19.3), p < 0.001. Multivariable analysis showed that only Hb and age significantly predicted all cause post-discharge mortality. ROC analysis for all cause mortality showed AUC for hemoglobin 0.688 (95% CI 0.782−0.594), p < 0.001; and for age 0.735 (95% CI 0.651−0.819) p < 0.001. A group of 59 subjects with hemoglobin < 10.5 g/dL showed mortality rate of 16.9% (OR for mortality 4.19 (95% CI 1.82−9.65), p-value < 0.00, while among 79 patients with Hb > 14.3 g/dL only one death was detected. Interestingly, patients in age > 64 years hemoglobin levels < 13.2 g/dL compared to patients in the same age but with >13.2 g/dL showed OR 3.6 with 95% CI 1.3−10.1 p = 0.012 for death after the discharge. Conclusions: Lower haemoglobin measured in the acute phase especially in patients in age above 64 years showed significant impact on the prognosis and clinical outcomes in PE survivors.
据报道,血红蛋白浓度降低可预测包括充血性心力衰竭和冠状动脉疾病在内的各种心血管疾病患者的长期预后。我们推测血红蛋白水平可能有助于急性肺栓塞首次发作后出院后的预后评估。因此,本研究的目的是评估因首次急性肺栓塞发作入院时测得的血红蛋白水平降低对至少2年随访期间出院后全因死亡率的潜在预后价值。方法:这是一项对首次肺栓塞发作的连续幸存者进行的前瞻性、单中心、随访、观察性队列研究。患者按照欧洲心脏病学会(ESC)现行指南进行管理。出院后,所有肺栓塞幸存者在我们的门诊至少随访24个月。结果:在402例连续肺栓塞幸存者的2年随访期间,29例(7.2%)患者死亡。非幸存者比幸存者年龄更大,分别为81岁(40 - 93岁)和63岁(18 - 97岁),p < 0.001;非幸存者的简化肺栓塞严重性指数(sPESI)更高,分别为2(0 - 4)和1(0 - 5),p < 0.001,这是由更高的肿瘤发生率驱动的(37.9%对16.6%,p < 0.001);且入院时血红蛋白(Hb)水平更低,分别为11.7 g/dL(6 - 14.8)和13.1 g/dL(3.1 - 19.3),p < 0.001。多变量分析表明,只有Hb和年龄显著预测出院后全因死亡率。全因死亡率的ROC分析显示,血红蛋白的曲线下面积(AUC)为0.688(95%可信区间0.782 - 0.594),p < 0.001;年龄的AUC为0.735(95%可信区间0.651 - 0.819),p < 0.001。一组59名血红蛋白<10.5 g/dL的受试者的死亡率为16.9%(死亡率的比值比(OR)为4.19(95%可信区间1.82 - 9.65),p值<0.00),而在79名Hb>14.3 g/dL的患者中仅检测到1例死亡。有趣的是,64岁以上血红蛋白水平<13.2 g/dL的患者与同年龄但血红蛋白>13.2 g/dL的患者相比,出院后死亡的OR为3.6,95%可信区间为1.3 - 10.1,p = 0.012。结论:急性期测得的较低血红蛋白水平,尤其是64岁以上患者,对肺栓塞幸存者的预后和临床结局有显著影响。